Jillian L. Descourouez

Fosfomycin Synergy <i>In Vitro</i> with Amoxicillin, Daptomycin, and Linezolid against Vancomycin-Resistant Enterococcus faecium from Renal Transplant Patients with Infected Urinary Stents

Jillian L. Descourouez, Margaret R. Jorgenson, Justine E. Wergin et al. · Antimicrobial Agents and Chemotherapy · 2012 · 74 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +15

Vancomycin Prophylaxis for Prevention of <i>Clostridium difficile</i> Infection Recurrence in Renal Transplant Patients

Lindsey E. Splinter, Luiza Kerstenetzky, Margaret R. Jorgenson et al. · Annals of Pharmacotherapy · 2017 · 32 citations

Medicine, Infectious Diseases, Pharmacotherapy +14

Risk of opportunistic infection in kidney transplant recipients with cytomegalovirus infection and associated outcomes

Margaret R. Jorgenson, Jillian L. Descourouez, Brianna Cardinale et al. · Transplant Infectious Disease · 2019 · 29 citations

Medicine, Infectious Diseases, Nephrology +17

Real world experience with conversion from valganciclovir to letermovir for cytomegalovirus prophylaxis: Letermovir reverses leukopenia and avoids mycophenolate dose reduction

Margaret R. Jorgenson, Jillian L. Descourouez, Christopher M. Saddler et al. · Clinical Transplantation · 2023 · 21 citations · Full text

Medicine, Infectious Diseases, Pharmacotherapy +17

The addition of adjunctive letermovir to valganciclovir for refractory cytomegalovirus viremia in kidney transplant recipients

Margaret R. Jorgenson, Jillian L. Descourouez, Neetika Garg et al. · Transplant Infectious Disease · 2021 · 20 citations

Medicine, Infectious Diseases, Pharmacotherapy +17